AptarGroup Inc (ATR) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets.
Total Assets Chart for AptarGroup Inc
AptarGroup Inc (ATR) total assets for FY2025 were USD 5.3B, a 18.5% change from FY2024. AptarGroup Inc's total assets grew from USD 301.5M in 1992 to USD 5.3B in 2025 (1642.2% over 33 years). Total assets compound annual growth rate: 5-year CAGR of 5.7%, 10-year CAGR of 8.0%, 20-year CAGR of 7.0%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $7.65B
- Implied Share Price
- $120.25
- Enterprise Value
- $9.15B
- Revenue (TTM)
- $3.93B
- EBITDA
- $798.40M
- Profit Margin
- 9.22%
- Trailing P/E
- 21.78
- Forward P/E
- 19.76
- Price/Book (MRQ)
- 3.02
- Price/Sales (TTM)
- 1.94
- EV/EBITDA
- 11.08
- EV/Revenue
- 2.33
- Dividend Yield
- 1.57%
- Book Value
- $41.33
- Free Cash Flow (FY2025)
- $299.58M
- Free Cash Flow Yield
- 3.92%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.